ASH: Roche’s Polivy set to unlock $2B market in newly diagnosed lymphoma with practice-changing data
The guessing is over. Roche has detailed new Polivy data that could change nearly two decades of treatment standards in newly diagnosed lymphoma—while opening up a bl...
Continue Reading →
